Carrageenan
Highest phase reached
Phase 2
Drug type
Unknown
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Unknown
- Drug name
- Carrageenan
- aec carrageenan gel
- Aec carrageenan gel
- aec carrageenan powder
- Aec carrageenan powder
- calcium carageenin
- Calcium carageenin
- calcium carrageenan
- Calcium carrageenan
- calcium carrageenate
- Calcium carrageenate
- carrageenan
- Carrageenan
- CARRAGEENAN [EP MONOGRAPH]
- CARRAGEENAN [FCC]
- CARRAGEENAN [HSDB]
- CARRAGEENAN [II]
- CARRAGEENAN [MART.]
- CARRAGEENAN [MI]
- CARRAGEENAN [VANDF]
- carrageenan calcium
- Carrageenan calcium
- carrageenan containing gel
- carrageenan ep monograph
- carrageenan fcc
- carrageenan hsdb
And 54 more, listed on the interactive page.
- CAS registry numbers
- 9000-07-1
- ChEMBL ID
- CHEMBL2108264
- FDA ingredient codes (UNII)
- 5C69YCD2YJ
- 1368862
- 1593445
- First in class
- No
- Orphan designation
- No
- Condition
- Papillomavirus Infections
- Highest recorded phase
- 2
- Condition identifier
- EFO:0001668
- Subject identifier
- D030361
- Condition
- Conjunctivitis, Viral
- Highest recorded phase
- 2
- Condition identifier
- EFO:0008571
- Subject identifier
- D003236
- Condition
- Severe Acute Respiratory Syndrome
- Highest recorded phase
- 1
- Condition identifier
- MONDO:0100096
- Subject identifier
- D045169
- Condition identifier
- EFO_0001668
- Highest recorded phase
- 2
- Condition identifier
- EFO_0008571
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0043541
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0100096
- NCT02382419
- NCT03009799
- NCT04701710
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (107)
- A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity
- A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome
- A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization
- A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)
- A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
- Acetylated Natural Nucleotides in Treating Hand-foot Syndrome
- Anti-calculus Efficacy of a Dentrifice Containing Sodium Pyrophosphate and Potassium Pyrophosphate in Heavy Calculus Formers
- Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia
- Bioadhesive Film of Acmella Oleracea (Jambu) in the Reduction of Post-bleaching Dental Sensitivity Caused by Bleaching With 35% Hydrogen Peroxide.
- Ca-hydroxyapatite, Fluoroapatite, and Mg-Zn-hydroxyapatite for Dentin Hypersensitivity Management
- Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
- Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model
- Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia
- Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
- Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel Erosion
- Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
- Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
- Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
In development for (3)
- COVID-19 Phase 1
- Human papilloma virus infection Phase 2
- Viral conjunctivitis Phase 2